Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Novel mutations in mitochondrial carrier family gene SLC25A38, causing congenital sideroblastic anemia in Iranian families, identified by whole exome sequencing.

Mehri M, Zarin M, Ardalani F, Najmabadi H, Azarkeivan A, Neishabury M.

Blood Cells Mol Dis. 2018 Jul;71:39-44. doi: 10.1016/j.bcmd.2018.02.002. Epub 2018 Feb 22.

PMID:
29499877
2.

Electromobility Shift Assay Reveals Evidence in Favor of Allele-Specific Binding of RUNX1 to the 5' Hypersensitive Site 4-Locus Control Region.

Dehghani H, Ghobakhloo S, Neishabury M.

Hemoglobin. 2016 Aug;40(4):236-9. doi: 10.1080/03630269.2016.1189931.

PMID:
27492765
3.

The Impact of XmnI-HBG2, BCL11A and HBS1L-MYB Single Nucleotide Polymorphisms on Hb F Variation of Hematologically Normal Iranian Individuals.

Keyhani E, Jafari Vesiehsari M, Talebi Kakroodi S, Darabi E, Zamani F, Karimlou M, Kamali K, Neishabury M.

Hemoglobin. 2016 Jun;40(3):198-201. doi: 10.3109/03630269.2016.1160920.

PMID:
27117569
4.

The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.

Neishabury M, Zamani F, Keyhani E, Azarkeivan A, Abedini SS, Eslami MS, Kakroodi ST, Vesiehsari MJ, Najmabadi H.

Blood Cells Mol Dis. 2013 Aug;51(2):80-4. doi: 10.1016/j.bcmd.2013.02.007. Epub 2013 Mar 28.

PMID:
23541515
5.

The XmnI and BCL11A single nucleotide polymorphisms may help predict hydroxyurea response in Iranian β-thalassemia patients.

Banan M, Bayat H, Azarkeivan A, Mohammadparast S, Kamali K, Farashi S, Bayat N, Khani MH, Neishabury M, Najmabadi H.

Hemoglobin. 2012;36(4):371-80. doi: 10.3109/03630269.2012.691147. Epub 2012 Jun 11.

PMID:
22686296
6.

The modifying effect of Xmn1-HBG2 on thalassemic phenotype is associated with its linked elements in the beta globin locus control region, including the palindromic site at 5'HS4.

Neishabury M, Zamani S, Azarkeivan A, Abedini SS, Darvish H, Zamani F, Najmabadi H.

Blood Cells Mol Dis. 2012 Jan 15;48(1):1-5. doi: 10.1016/j.bcmd.2011.10.001. Epub 2011 Oct 28.

PMID:
22036762
7.

Analyzing 5'HS3 and 5'HS4 LCR core regions and NF-E2 in Iranian thalassemia intermedia patients with normal or carrier status for beta-globin mutations.

Neishabury M, Azarkeivan A, Oberkanins C, Abedini SS, Zamani S, Najmabadi H.

Blood Cells Mol Dis. 2011 Mar 15;46(3):201-5. doi: 10.1016/j.bcmd.2010.12.007. Epub 2011 Jan 12.

PMID:
21232998
8.

A report of 8 cases with hemoglobin H disease in an Iranian family.

Azarkeivan A, Neishabury M, Hadavi V, Esteghamat F, Enrahimkhani S, Najmabadi H.

Pediatr Hematol Oncol. 2010 Aug;27(5):405-12. doi: 10.3109/08880010903536201. Erratum in: Pediatr Hematol Oncol. 2011 Feb;28(1):89. Azita, Azarkeivan [corrected to Azarkeivan, Azita]; Fatemehsadat, Esteghamat [corrected to Esteghamat, Fatemehsadat]; Hossein, Najmabadi [corrected to Najmabadi, Hossein].

PMID:
20670167
9.
10.

Molecular mechanisms underlying thalassemia intermedia in Iran.

Neishabury M, Azarkeivan A, Oberkanins C, Esteghamat F, Amirizadeh N, Najmabadi H.

Genet Test. 2008 Dec;12(4):549-56. doi: 10.1089/gte.2008.0018.

PMID:
18939939
11.

alpha-globin gene deletion and point mutation analysis among in Iranian patients with microcytic hypochromic anemia.

Garshasbi M, Oberkanins C, Law HY, Neishabury M, Kariminejad R, Najmabadi H.

Haematologica. 2003 Oct;88(10):1196-7. Review.

12.

High prevalence of the -alpha3.7 deletion among thalassemia patients in Iran.

Neishabury M, Oberkanins C, Moheb LA, Pourfatholuah AA, Kahrizi K, Keyhany E, Krugluger W, Najmabadi H.

Hemoglobin. 2003 Feb;27(1):53-5. No abstract available.

PMID:
12603096
13.

The Iranian Human Mutation Gene Bank: a data and sample resource for worldwide collaborative genetics research.

Najmabadi H, Neishabury M, Sahebjam F, Kahrizi K, Shafaghati Y, Nikzat N, Jalalvand M, Aminy F, Hashemi SB, Moghimi B, Noorian AR, Jannati A, Mohammadi M, Javan K; Iranian Human Mutation Gene Bank.

Hum Mutat. 2003 Feb;21(2):146-50.

PMID:
12552562
14.

Rare and unexpected mutations among Iranian beta-thalassemia patients and prenatal samples discovered by reverse-hybridization and DNA sequencing.

Najmabadi H, Pourfathollah AA, Neishabury M, Sahebjam F, Krugluger W, Oberkanins C.

Haematologica. 2002 Oct;87(10):1113-4. No abstract available.

Supplemental Content

Loading ...
Support Center